Literature DB >> 13679791

Decline in annual incidence of varicella--selected states, 1990-2001.

.   

Abstract

Varicella (chickenpox) is a common, highly infectious, and vaccine-preventable disease. Before the introduction of the live attenuated varicella vaccine in 1995, approximately 4 million cases of varicella occurred annually in the United States, resulting in approximately 11,000 hospitalizations and 100 deaths. In 1996, the Advisory Committee on Immunization Practices (ACIP) recommended routine vaccination of all children at age 12-18 months, catch-up vaccination of all susceptible children before age 13 years, and vaccination of susceptible persons with close contact to persons at high risk for serious complications. In 1999, ACIP updated these recommendations to include vaccination requirements for child care and school entry and for postexposure; ACIP also strengthened recommendations for vaccination of susceptible adults and indicated that varicella vaccine should be considered for outbreak control. Changes in the national annual reported incidence of varicella disease during 1972-1997 have been reported previously. This report summarizes trends in the annual reported incidence of varicella disease in selected states during 1990-2001. The findings underscore the continued need to improve varicella surveillance to monitor the impact of the varicella vaccination program and assess any changes in varicella transmission and disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679791

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  15 in total

Review 1.  Should the UK introduce varicella vaccine?

Authors:  Marion Roderick; Athimalaipet V Ramanan; Adam Finn
Journal:  Arch Dis Child       Date:  2007-11-08       Impact factor: 3.791

2.  Is it time to introduce varicella vaccine to our children?

Authors:  T I Yousif; A Ibrahim; M Nadeem
Journal:  Ir J Med Sci       Date:  2016-05-09       Impact factor: 1.568

Review 3.  Varicella-zoster virus (chickenpox) infection in pregnancy.

Authors:  Ronald F Lamont; Jack D Sobel; D Carrington; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Edi Vaisbuch; Roberto Romero
Journal:  BJOG       Date:  2011-05-18       Impact factor: 6.531

Review 4.  Neuroimaging of herpesvirus infections in children.

Authors:  Henry J Baskin; Gary Hedlund
Journal:  Pediatr Radiol       Date:  2007-05-22

5.  Varicella disease in Beijing in the era of voluntary vaccination, 2007 to 2010.

Authors:  Li Lu; Chengbin Wang; Luodan Suo; Juan Li; Weixiang Liu; Xinghuo Pang; Jane F Seward
Journal:  Pediatr Infect Dis J       Date:  2013-08       Impact factor: 2.129

Review 6.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

7.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

8.  Incidence and effects of Varicella Zoster Virus infection on academic activities of medical undergraduates--a five-year follow-up study from Sri Lanka.

Authors:  Suneth B Agampodi; Samath D Dharmaratne; Vasanthi Thevanesam; Sameera Dassanayake; Prabhashini Kumarihamy; Ashani Ratnayake
Journal:  BMC Infect Dis       Date:  2010-05-14       Impact factor: 3.090

Review 9.  Impact of varicella vaccine on varicella-zoster virus dynamics.

Authors:  D Scott Schmid; Aisha O Jumaan
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination.

Authors:  James G Donahue; Burney A Kieke; Paul M Gargiullo; Aisha O Jumaan; Nicholas R Berger; Jeremy S McCauley; Edward A Belongia
Journal:  Am J Public Health       Date:  2010-01-14       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.